Investing.com - Aphria reported third quarter earnings that missed analysts' expectations on Monday and revenue that fell short of forecasts.
The firm reported earnings per share of C$-1.14 on revenue of C$153.64M. Analysts polled by Investing.com anticipated EPS of C$-0.0418 on revenue of C$162.4M. .
Aphria shares lost 11.59% to trade at C$18.000 in intra-day trade following the report.
For the year, Aphria shares are up 104.55%, outperforming the S&P/TSX which is up 10.07% year to date.
Aphria follows other major Healthcare sector earnings this month
On Tuesday, March 23, 2021, Terrascend reported first quarter EPS of C$-0.72 on revenue of C$65M, compared to forecasts of EPS of C$0.015 on revenue of C$64.18M.
Trillium Therapeutics earnings beat analyst's expectations on Friday, March 19, 2021, with first quarter EPS of C$1.1 on revenue of C$0.00. Investing.com analysts expected EPS of C$-0.2889 on revenue of C$0.00
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar